SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-16-163501
Filing Date
2016-12-22
Accepted
2016-12-22 16:48:14
Documents
7

Document Format Files

Seq Description Document Type Size
1 8-K a16-23618_18k.htm 425 61758
2 EX-2.1 a16-23618_1ex2d1.htm EX-2.1 670820
3 EX-10.1 a16-23618_1ex10d1.htm EX-10.1 112143
4 EX-10.2 a16-23618_1ex10d2.htm EX-10.2 111576
5 EX-10.3 a16-23618_1ex10d3.htm EX-10.3 32575
6 EX-10.4 a16-23618_1ex10d4.htm EX-10.4 32792
7 EX-99.1 a16-23618_1ex99d1.htm EX-99.1 19412
  Complete submission text file 0001104659-16-163501.txt   1042843
Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005
Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834
Dipexium Pharmaceuticals, Inc. (Filed by) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005
Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834
Dipexium Pharmaceuticals, Inc. (Subject) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-36351 | Film No.: 162067094
SIC: 2834 Pharmaceutical Preparations